AMN

Hagan Mark Christopher

Known title: Chief Information and DigitalCIK: 0001806483

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.

this person other insiders at AMN

Transaction History

AMN▲ Buy$0
AMN▼ Sell$12K
AMN▲ Buy$0
AMN▼ Sell$18K
AMN▲ Buy$0
AMN▼ Sell$51K
AMN▲ Buy$0
AMN▼ Sell$69K
AMN▲ Buy$0
AMN▼ Sell$25K
AMN▲ Buy$0
AMN▲ Buy$0
AMN▲ Buy$0
AMN▼ Sell$24K
AMN▼ Sell$15K
AMN▼ Sell$15K
AMN▲ Buy$0
AMN▼ Sell$111K
AMN▲ Buy$0
AMN▼ Sell$37K
AMN▲ Buy$0
AMN▼ Sell$38K
AMN▲ Buy$0
AMN▼ Sell$108K
AMN▲ Buy$0
AMN▼ Sell$73K
AMN▼ Sell$1.1M
AMN▼ Sell$510K
AMN▲ Buy$0
AMN▲ Buy$0
AMN▼ Sell$114K
AMN▲ Buy$0
AMN▼ Sell$288K
AMN▲ Buy$0
AMN▼ Sell$48K
AMN▲ Buy$0
AMN▼ Sell$45K
AMN▲ Buy$0
AMN▼ Sell$93K
AMN▲ Buy$0
AMN▼ Sell$154K
AMN▲ Buy$0
AMN▼ Sell$632K
AMN▼ Sell$137K
AMN▲ Buy$0
AMN▼ Sell$372K
AMN▲ Buy$0
AMN▼ Sell$64K
AMN▲ Buy$0
AMN▼ Sell$95K
AMN▲ Buy$0
AMN▼ Sell$184K
AMN▲ Buy$0
AMN▼ Sell$65K

We use analytics to understand how market-wall is used. No personal data is sold.